Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
2006 Standout
Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
2014 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
A mathematical model to estimate global hepatitis B disease burden and vaccination impact
2005
The impact of vaccines on pneumonia: Key lessons from Haemophilus influenzae type b conjugate vaccines
2008
Vaccinations and the Risk of Relapse in Multiple Sclerosis
2001
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
2015 Standout
Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination
1996
Hepatitis C Virus Infection
2001 Standout
The Emergence of Hepatitis B as a Sexually Transmitted Disease
1990
The need for more aggressive follow-up of children born to hepatitis B surface antigen-positive mothers: lessons from the Louisiana Perinatal Hepatitis B Immunization Program
1996
Impact of hepatitis B immunization, Europe and worldwide
2003
Hepatitis B Virus Infection: Epidemiology and Vaccination
2006 Standout
Immunologic correlates of protection induced by vaccination
2001
Clearance of Hepatitis B e Antigen in Patients With Chronic Hepatitis B and Genotypes A, B, C, D, and F
2007
A multicentre assessment of the specificity of ten anti‐HBc screening tests
1995
Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study
2005
Sexual dimorphism of humoral immunity with human vaccines
2008
Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease
2016
Botulinum Toxin as a Biological Weapon
2001 Standout
Hepatitis C vaccine: supply and demand
2008
Outbreak of Clinically Mild Botulism Type E Illness from Home-Salted Fish in Patients Presenting with Predominantly Gastrointestinal Symptoms
2007
Guillain–Barré Syndrome
2012 Standout
Hepatitis B virus infection
2009 Standout
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
2017 Standout
Response to Hepatitis B Vaccine in HIV‐1–Positive Subjects Who Test Positive for Isolated Antibody to Hepatitis B Core Antigen: Implications for Hepatitis B Vaccine Strategies
2005
Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areasr
1996
The Meaning of Translational Research and Why It Matters
2008 Standout
Brucellosis
2005 Standout
Hepatitis B vaccines
2003
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: A 16-year population-based study
2000
Multiple sclerosis
2008 Standout
Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease
1998
Management of Hepatocellular Carcinoma *
2005 Standout
Antibody neutralization and escape by HIV-1
2003 StandoutNature
Diabetes in Asia
2009 Standout
Duration of Hepatitis B Immunity in Low Risk Children Receiving Hepatitis B Vaccinations From Birth
2004
Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children
1999
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
Clinical Features in Patients with Long-Lasting Macrophagic Myofasciitis
2014
Status of hepatitis B immunization programmes in 1998
1998
Chronic hepatitis B
2007 Standout
The natural history of chronic hepatitis B virus infection #
2009
Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity
2012
Immunogenicity of Hepatitis B vaccines
1998
Cell mediated and antibody immune response to inactivated hepatitis A vaccine
2005
Chronic hepatitis B: Update 2009 #
2009 Standout
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
Botulism: The Present Status of the Disease
1995
Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine
2001
Comparative Safety of Two Recombinant Hepatitis B Vaccines in Children
1998
Hepatitis B Vaccination and the Risk of Multiple Sclerosis
2001
Foodborne Illness Acquired in the United States—Major Pathogens
2010 Standout
Chronic Liver Disease among Alaska-Native People, 2003–2004
2009
Gastric cancer
2020 Standout
Stress-induced immune dysfunction: implications for health
2005 Standout
The Gambia Hepatitis Intervention Study: Follow-Up of a Cohort of Children Vaccinated against Hepatitis B
1992
Iron Deficiency and Helicobacter pylori Infection in the United States
2005
Vaccines and Guillain-Barré Syndrome
2009
Tularemia as a Biological Weapon
2001 Standout
The global impact of vaccination against hepatitis B: A historical overview
2008
Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study
2005
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Sex differences in immune responses
2016 Standout
Amoebiasis
2003 Standout
Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
2011 StandoutNobel
The Risk of Transfusion-Transmitted Viral Infections
1996 Standout
Hepatocellular Carcinoma
2011 Standout
Hepatitis B vaccine – do we need boosters?
2003
Global Epidemiology of Hepatitis B Virus
2004
Clinical spectrum of botulism
1998
Prevalence, Patterns, and Course of Past Hepatitis B Virus Infection in Intravenous Drug Users With Hiv-1 Infection
2000
Multiple sclerosis
2002 Standout
Isolated Antibody to Hepatitis B Core Antigen in Human Immunodeficiency Virus Type-1--Infected Individuals
2003
Food-Related Illness and Death in the United States
1999 Standout
Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants
2002 Standout
Endemic, Notifiable Bioterrorism-Related Diseases, United States, 1992–1999
2003
Enhanced SARS-CoV-2 neutralization by dimeric IgA
2020 StandoutNobel
Inflammatory Muscle Diseases
2015 Standout
Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus
2001
A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP): Part 1: Immunization of Infants, Children, and Adolescents
2005
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Differences in Response to a Hepatitis B Vaccine Booster Dose Among Alaskan Children and Adolescents Vaccinated During Infancy
2007
Risk and Management of Blood-Borne Infections in Health Care Workers
2000
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Prevention of Hepatitis A Through Active or Passive Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
1999 Standout
Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial
2015
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades
2002
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Summary of notifiable diseases--United States, 2002.
2004 Standout
An Outbreak of Type A Botulism Associated with a Commercial Cheese Sauce
1996
Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains ofHelicobacter pyloriand prevents benzo[a]pyrene-induced stomach tumors
2002
Iron-Deficiency Anemia
2015 Standout
Foodborne Botulism in the United States, 1990–2000
2004
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Renal grafts from anti‐hepatitis B core‐positive donors: a quantitative review of the literature
2012
Botulism in the United States: A Clinical and Epidemiologic Review
1998
Diagnosis and Monitoring of Hepatic Injury. I. Performance Characteristics of Laboratory Tests
2000
Reshaping de Novo Protein Switches into Bioresponsive Materials for Biomarker, Toxin, and Viral Detection
2022 StandoutNobel
Neurotoxins Affecting Neuroexocytosis
2000 Standout
How I treat unexplained refractory iron deficiency anemia
2013
Childhood Hepatitis B Virus Infections in the United States Before Hepatitis B Immunization
2001
Incidence of hepatocellular carcinoma according to hepatitis B virus genotype in Alaska Native people
2016
Correlates of Protection Induced by Vaccination
2010 Standout
Protective Anti-Hepatitis B Virus Responses in Rhesus Monkeys Primed with a Vectored Measles Virus and Boosted with a Single Dose of Hepatitis B Surface Antigen
2009
Works of Robert B. Wainwright being referenced
Decline of Haemophilus influenzae type b disease in a region of high risk
1994
Secular Trends in Hepatitis A Virus Infection among Alaska Natives
1993
Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen
1992
Protection Provided by Hepatitis B Vaccine in a Yupik Eskimo Population--Results of a 10-Year Study
1997
Immunogenicity Of An Inactivated Hepatitis A Vaccine In Alaska Native Children And Native And Non-Native Adults
1995
Elimination of New Chronic Hepatitis B Virus Infections: Results of the Alaska Immunization Program
2000
Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants
1993
Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons
1992
Clinical and Laboratory Comparison of Botulism from Toxin Types A, B, and E in the United States, 1975-1988
1992
Increases in Levels of Antibody to Hepatitis B Surface Antigen in an Immunized Population
1998
Food-Borne Botulism in Alaska, 1947-1985: Epidemiology and Clinical Findings
1988
Protection Provided by Hepatitis B Vaccine in a Yupik Eskimo Population
1991
Duration of Immunogenicity and Efficacy of Hepatitis B Vaccine in a Yupik Eskimo Population
1989
Protection provided by hepatitis B vaccine in a Yupik Eskimo population. Seven-year results
1991
Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population
1989
High Prevalence of Helicobacter pylori in the Alaska Native Population and Association with Low Serum Ferritin Levels in Young Adults
2000
Seroprevalence of Hepatitis B Viral Markers in 52,000 Alaska Natives
1993